Archive for October 2022

Nasodine patent granted in Singapore

We are pleased to announce that our patent covering Nasodine ® Nasal Spray1 as a treatment and preventative for the common cold has been granted in Singapore. This brings the number of countries where Firebrick’s core patent has been granted to 27, including: The patent is still pending in Canada and Japan. The pending application…